Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for University of Virginia Health System University Hospital located at 1215 Lee St Pfs, Charlottesville, VA, 22908 & includes data from NPIs 1659487452, 1780630608, 1184731507
Dexur analyzed Q2 2017 (April to June 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for University of Virginia Health System University Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 2,739 | 2,624 | ||||||||||
Surgical | 1,152 | 1,123 | ||||||||||
Non Surgical | 1,587 | 1,501 | ||||||||||
Cardiovascular | 532 | 506 | ||||||||||
General Surgery | 332 | 312 | ||||||||||
General Medicine | 327 | 294 | ||||||||||
Orthopedics | 304 | 302 | ||||||||||
Gastroenterology & Endocrinology | 225 | 221 | ||||||||||
Neurology | 195 | 182 | ||||||||||
Pulmonology | 194 | 185 | ||||||||||
Urology | 191 | 189 | ||||||||||
Spine | 130 | 129 | ||||||||||
Oncology & Hematology | 112 | 109 | ||||||||||
Psychiatry & Mental Disorders | 69 | 68 | ||||||||||
Colorectal | 64 | 63 | ||||||||||
Obstetrics & Gynecology | 32 | 32 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 25 | 25 |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Vascular Procedures | ||||||||||||
DRG 254: OTHER VASCULAR PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Acute Myocardial Infarction | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Coronary Bypass | ||||||||||||
DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Endovascular Procedures | ||||||||||||
DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
Percutaneous Intracardiac Procedures | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||
Hypertension |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Chest Procedures | ||||||||||||
DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Ecmo Or Tracheostomy With Mv >96 Hours Or Pdx Except Face, Mouth And Neck | ||||||||||||
DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | ||||||||||||
Extracranial Procedures | ||||||||||||
DRG 039: EXTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
Pancreas, Liver And Shunt Procedures | ||||||||||||
Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
Other O.R. Procedures For Injuries |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Poisoning And Toxic Effects Of Drugs | ||||||||||||
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
Complications Of Treatment | ||||||||||||
Other Multiple Significant Trauma | ||||||||||||
Cirrhosis And Alcoholic Hepatitis |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||
DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
Medical Back Problems | ||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Diabetes | ||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
DRG 372: MAJOR GASTROINTESTINAL DISORDERS AND PERITONEAL INFECTIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
G.I. Obstruction | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
Disorders Of Pancreas Except Malignancy |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Seizures | ||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Disorders Of Nervous System | ||||||||||||
Nonspecific Cerebrovascular Disorders | ||||||||||||
Cranial And Peripheral Nerve Disorders | ||||||||||||
Degenerative Nervous System Disorders |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory Infections And Inflammations | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
Pulmonary Embolism | ||||||||||||
Pneumothorax |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney Transplant | ||||||||||||
DRG 652: KIDNEY TRANSPLANT | ||||||||||||
Kidney And Ureter Procedures |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spinal Fusion Except Cervical | ||||||||||||
DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cervical Spinal Fusion | ||||||||||||
DRG 472: CERVICAL SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 473: CERVICAL SPINAL FUSION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Spinal Fusion Except Cervical With Spinal Curvature / Malignancy / Infection Or Extensive Fusions |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
Lymphoma And Non-Acute Leukemia |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Organic Disturbances And Intellectual Disability | ||||||||||||
DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Apr 2017 to Jun 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Virginia Total Hospitalizations (Apr 2017 to Jun 2017) | Virginia Total Hospitalizations After Exclusion | Virginia Total Users | Virginia SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2017 to Jun 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures | ||||||||||||
DRG 328: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |